The combination NAT2 slow-CYP1A1 rapid acetylator were at highest risk for lung adenocarcinoma in non-smoking females [36] or the NAT2-CYP1A1 rapid acetylators may also predispose higher risk to lung cancer in female never smokers [22]. The gene discussed is NAT2; the disease is lung carcinoma.